277 related articles for article (PubMed ID: 8022720)
21. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer screening: an overview of available methods and current recommendations.
Early DS
South Med J; 1999 Mar; 92(3):258-65. PubMed ID: 10094264
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of colon cancer screening.
Lieberman D
Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
[TBL] [Abstract][Full Text] [Related]
25. [Screening for colorectal cancer and polyps].
Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
27. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
28. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
[TBL] [Abstract][Full Text] [Related]
29. Screening for colorectal cancer: the cost to find an advanced adenoma.
McGrath JS; Ponich TP; Gregor JC
Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
[TBL] [Abstract][Full Text] [Related]
30. Colon cancer screening in 2010: an up-date.
Weizman AV; Nguyen GC
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):181-8. PubMed ID: 20485255
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening: present strategies and future prospects.
Marshall JB
Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
[TBL] [Abstract][Full Text] [Related]
32. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
33. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
34. Screening for colorectal cancer--now and the near future.
Bromer MQ; Weinberg DS
Semin Oncol; 2005 Feb; 32(1):3-10. PubMed ID: 15726501
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
36. [Individual screening for colorectal cancer: which strategy for which patient?].
Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
38. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
39. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of diagnostic examinations for colorectal polyps.
Menardo G
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
